CDKN2A and androgen insensitivity syndrome: To validate the differential gene expression, qPCR was performed for two selected genes (CDKN2A and NCAM1), and the normalized Cq method (2−∆Cq) was used to calculate the relative gene expression in normal and CIN3/AIS biopsies [19].